TRACON Pharmaceuticals Inc (NASDAQ: TCON): Analyst View Points To Future Growth
BlackRock Fund Advisors has recently announced that it has increased stake in TRACON Pharmaceuticals Inc (NASDAQ:TCON) by 0.04%. After grabbing 0.27 million shares, the institutional investor is now in possession of 102.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.86% having worth around $46869.0. Moreover, Geode Capital […]
Better Times Ahead For TRACON Pharmaceuticals Inc (NASDAQ: TCON)?
BlackRock Fund Advisors has recently announced that it has increased stake in TRACON Pharmaceuticals Inc (NASDAQ:TCON) by 0.04%. After grabbing 0.27 million shares, the institutional investor is now in possession of 102.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.86% having worth around $54903.0. Moreover, Geode Capital […]
